<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>After focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo>, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha deteriorates <z:hpo ids='HP_0002181'>cerebral edema</z:hpo> and survival rate </plain></SENT>
<SENT sid="1" pm="."><plain>Therefore, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha neutralization could reduce cerebral microvascular permeability in <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Left middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> for 120 mins followed by reperfusion was performed with the thread method under <z:chebi fb="2" ids="5615">halothane</z:chebi> anesthesia in Sprague-Dawley rats </plain></SENT>
<SENT sid="3" pm="."><plain>Antirat <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha neutralizing monoclonal antibody with a rat IgG Fc portion (15 mg/kg) was infused intravenously right after reperfusion </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0001297'>Stroke</z:hpo> index score, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume, cerebral specific gravity, and the endogenous expression of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha, matrix metalloproteinase (MMP)-2, MMP-9, and membrane type 1-MMP in the brain tissue were quantified in the ischemic and matched contralateral nonischemic hemisphere </plain></SENT>
<SENT sid="5" pm="."><plain>In the antitumor <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha neutralizing antibody-treated rats, <z:mpath ids='MPATH_124'>infarct</z:mpath> volume was significantly reduced (P=0.014, n=7; respectively), and cerebral specific gravity was dramatically increased in the cortex and caudate putamen (P&lt;0.001, n=7; respectively) in association with a reduction in MMP-9 and membrane type 1-MMP upregulation </plain></SENT>
<SENT sid="6" pm="."><plain><z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">Tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha in the brain tissue was significantly elevated in the ischemic hemisphere 6 h after reperfusion in the nonspecific IgG-treated rats (P=0.021, n=7) and was decreased in the antitumor <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha neutralizing antibody-treated rats (P=0.001, n=7) </plain></SENT>
<SENT sid="7" pm="."><plain>Postreperfusion treatment with antirat <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor-alpha neutralizing antibody reduced brain <z:mpath ids='MPATH_124'>infarct</z:mpath> volume and <z:hpo ids='HP_0002181'>cerebral edema</z:hpo>, which is likely mediated by a reduction in MMP upregulation </plain></SENT>
</text></document>